These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 17476279)

  • 1. Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential.
    Cheung AM; Wan TS; Leung JC; Chan LY; Huang H; Kwong YL; Liang R; Leung AY
    Leukemia; 2007 Jul; 21(7):1423-30. PubMed ID: 17476279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase activity among primary leukemia cells is associated with stem cell features and correlates with adverse clinical outcomes.
    Ran D; Schubert M; Pietsch L; Taubert I; Wuchter P; Eckstein V; Bruckner T; Zoeller M; Ho AD
    Exp Hematol; 2009 Dec; 37(12):1423-34. PubMed ID: 19819294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal hematopoietic stem cells within the AML bone marrow have a distinct and higher ALDH activity level than co-existing leukemic stem cells.
    Schuurhuis GJ; Meel MH; Wouters F; Min LA; Terwijn M; de Jonge NA; Kelder A; Snel AN; Zweegman S; Ossenkoppele GJ; Smit L
    PLoS One; 2013; 8(11):e78897. PubMed ID: 24244383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular signature of AML with increased ALDH activity suggests a stem cell origin.
    Blume R; Rempel E; Manta L; Saeed BR; Wang W; Raffel S; Ermakova O; Eckstein V; Benes V; Trumpp A; Ho AD; Lutz C
    Leuk Lymphoma; 2018 Sep; 59(9):2201-2210. PubMed ID: 29334844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M; Frankel AE; Alexander RL; Gerhard B; Hogge DE
    Cancer Res; 2002 Mar; 62(6):1730-6. PubMed ID: 11912147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSC(lo) ALDH(br) cells on hematopoietic recovery.
    Gündüz E; Demirel G; Bal C; Gulbas Z
    Cytotherapy; 2010 Dec; 12(8):1006-12. PubMed ID: 20735165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of leukemia stem cell candidates at diagnosis of acute myeloid leukemia and their clinical significance.
    Ran D; Schubert M; Taubert I; Eckstein V; Bellos F; Jauch A; Chen H; Bruckner T; Saffrich R; Wuchter P; Ho AD
    Exp Hematol; 2012 Feb; 40(2):155-65.e1. PubMed ID: 22024109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117).
    Blair A; Sutherland HJ
    Exp Hematol; 2000 Jun; 28(6):660-71. PubMed ID: 10880752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JmjC-domain containing histone demethylase 1B-mediated p15(Ink4b) suppression promotes the proliferation of leukemic progenitor cells through modulation of cell cycle progression in acute myeloid leukemia.
    Nakamura S; Tan L; Nagata Y; Takemura T; Asahina A; Yokota D; Yagyu T; Shibata K; Fujisawa S; Ohnishi K
    Mol Carcinog; 2013 Jan; 52(1):57-69. PubMed ID: 22086844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
    Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
    Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors.
    Feuring-Buske M; Gerhard B; Cashman J; Humphries RK; Eaves CJ; Hogge DE
    Leukemia; 2003 Apr; 17(4):760-3. PubMed ID: 12682634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
    Vercauteren S; Zapf R; Sutherland H
    Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable aldehyde dehydrogenase activity and effects on chemosensitivity of primitive human leukemic cells.
    Bogen A; Buske C; Hiddemann W; Bohlander SK; Christ O
    Exp Hematol; 2017 Mar; 47():54-63. PubMed ID: 27826122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34.
    Storms RW; Green PD; Safford KM; Niedzwiecki D; Cogle CR; Colvin OM; Chao NJ; Rice HE; Smith CA
    Blood; 2005 Jul; 106(1):95-102. PubMed ID: 15790790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
    van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
    Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants.
    Lioznov MV; Freiberger P; Kröger N; Zander AR; Fehse B
    Bone Marrow Transplant; 2005 May; 35(9):909-14. PubMed ID: 15765109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.